Synopsis of recent research by authors named "Anant Gokarn"
- Anant Gokarn's recent research primarily focuses on hematopoietic stem cell transplantation (HSCT) and its implications for various hematological conditions, including implications for graft versus host disease (GVHD) and the safety of novel therapeutic agents for these patients.
- His studies assess clinical outcomes related to different treatment regimens, such as the effectiveness of posaconazole prophylaxis against invasive fungal infections during acute myeloid leukemia induction therapy, and the long-term effects of combined chemotherapy and radiation therapy for advanced-stage Hodgkin lymphoma.
- Gokarn's work also explores innovative approaches to mitigate complications associated with HSCT, including measuring circulating tumor plasma cells as a noninvasive tumor burden assessment in multiple myeloma and investigating the signaling pathway of CD26 in post-transplant outcomes.
